Abstract
Diagnostic imaging with Nuclear Medicine has been used in examination of various types of cerebrovascular diseases. Recently, measurement of glucose metabolism, oxygen consumption and neurotransmitter function has been developed using PET. Radiopharmaceuticals for SPECT have been formulated after its clinical usefulness has been determined by the PET. The new examination with SPECT includes rCBF and receptor imaging. Clinical SPECT and PET which gives information not only physiological but also biochemical function will eventually play a vital role in patients examination near future. Clinical application of these examinations has been presented in this paper.